PPS_201812003_1_9_Supplement_2.docx (22.18 kB)View fileThis item contains files with download restrictions
DOCUMENT
PPS_201812003_1_8_Supplement_1_PDF.PDF (69.31 kB)View fileThis item contains files with download restrictions
DOCUMENT
PPS_201812003_1_8_Supplement_1.docx (36.5 kB)View fileThis item contains files with download restrictions
DOCUMENT
PPS_201812003_1_13_Supplement_6_PDF.PDF (61.34 kB)View fileThis item contains files with download restrictions
DOCUMENT
PPS_201812003_1_13_Supplement_6.docx (51.85 kB)View fileThis item contains files with download restrictions
DOCUMENT
PPS_201812003_1_12_Supplement_5_PDF.PDF (43.7 kB)View fileThis item contains files with download restrictions
DOCUMENT
PPS_201812003_1_12_Supplement_5.docx (20.55 kB)View fileThis item contains files with download restrictions
DOCUMENT
PPS_201812003_1_11_Supplement_4.pdf (96.8 kB)View fileThis item contains files with download restrictions
DOCUMENT
PPS_201812003_1_10_Supplement_3_PDF.PDF (65.11 kB)View fileThis item contains files with download restrictions
DOCUMENT
PPS_201812003_1_9_Supplement_2_PDF.PDF (48.34 kB)View fileThis item contains files with download restrictions
Next page
Previous page
1/1
Switch ViewSwitch between different file views
Thumbnail viewList viewFile view
11 filesFullscreen
Supplementary Material for: Positive Treatment Expectancies Reduce Clinical Pain and Perceived Limitations in Movement Ability Despite Increased Experimental Pain: A Randomized Controlled Trial on Sham Opioid Infusion in Patients with Chronic Back Pain
posted on 2019-07-12, 08:19authored bySchmitz J., Müller M., Stork J., Eichler I., Zöllner C., Flor H., Klinger R.
Background: Increasing evidence for the efficacy of analgesic placebo effects in laboratory studies with healthy persons raises the question whether placebos could be used to improve the treatment of pain patients. Expectancies play a central role in shaping analgesic placebo but also nocebo effects. Objectives: We investigated to what extent a sham opioid infusion (saline solution) produces sustained clinically relevant placebo and nocebo effects in chronic back pain patients. Methods: Fifty-nine patients received the sham opioid infusion applied via a large drain dressing and were compared to 14 control patients without intervention (natural history, NH) while experimental pain stimuli were applied. All subjects were told that the infusion would decrease pain although in rare cases pain increase would be possible (induction of expectancy). In addition, conditioning was introduced where the participants either experienced a decrease in experimental pain (n = 17; placebo conditioning), an increase (n = 21; nocebo conditioning), or no change (n = 21, no conditioning). Results: Compared to the NH group, all infusion groups showed positive treatment expectancies and significantly (p < 0.001) reduced clinical back pain (primary outcome) and pain-related disability (secondary outcome, assessed by self-reported functional capacity and perceived impairment of mobility). Even the nocebo conditioned group experiencing increased experimental pain developed positive treatment expectancies followed by reduced pain experience. Positive treatment expectancies and relief in clinical back pain were significantly positively correlated (r = 0.72, p < 0.01). Conclusions: These findings suggest that it may be beneficial to explicitly shape and integrate treatment expectancies into clinical pain management.